Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shusuke Mori
Human Soluble Recombinant Thrombomodulin, ART-123, Resolved Early Phase Coagulopathies, but Did Not Significantly Alter the 28 Day Outcome in the Treatment of DIC Associated With Infectious Systemic Inflammatory Response Syndromes
Journal of Clinical Medicine
Related publications
Benefit Profile of Recombinant Human Soluble Thrombomodulin in Sepsis-Induced DIC
Critical Care
Critical Care
Intensive Care Medicine
Phase I Study of Solulin, a Novel Recombinant Soluble Human Thrombomodulin Analogue
Thrombosis and Haemostasis
Hematology
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
JAMA - Journal of the American Medical Association
Medicine
Clinical Outcomes of Recombinant Human-Soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors
Anticancer Research
Medicine
Cancer Research
Oncology
Drug-Induced Thrombotic Thrombocytopenic Purpura Successfully Treated With Recombinant Human Soluble Thrombomodulin
Internal Medicine
Internal Medicine
Medicine
Soluble Siglec-8 Levels Are Detectable in Subjects With Myeloid Variant Hypereosinophilic Syndromes, but Not in Those With D816V KIT + Systemic Mastocytosis
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Enhanced Effect of Recombinant Human Soluble Thrombomodulin by Ultrasound Irradiation in Acute Liver Failure
Scientific Reports
Multidisciplinary
The Systemic Inflammatory Response in the Development of Ventilator-Associated Pneumonia
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Erratum to “Postpercutaneous Nephrolithotomy Systemic Inflammatory Response Syndrome Is Not Associated With Unplanned Readmission”
Urology
Urology
